SMTL ID : 6c3e.1

CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-dimer

Ligands

2 x EJY: 2-benzyl-5-nitro-1H-benzimidazole(Non-covalent)

EJY.1: 16 residues within 4Å: Chain A: K.48, L.73, V.78, V.79, L.81, L.93, M.95, L.132, V.137, H.139, I.157, A.158, D.159, L.160, S.164, F.165 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.73, A:V.78, A:L.81, A:L.132, A:V.137, A:D.159, A:F.165 Hydrogen bonds: A:V.79, A:D.159 pi-Stacking: A:H.139 EJY.2: 15 residues within 4Å: Chain B: K.48, L.73, V.78, V.79, L.93, M.95, L.132, V.137, H.139, I.157, A.158, D.159, L.160, L.162, S.164 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:L.73, B:V.78, B:L.132, B:V.137, B:D.159 Hydrogen bonds: B:V.79, B:D.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yoshikawa, M. et al., Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships. J. Med. Chem. (2018)

Release Date

2018-03-21

Peptides

Receptor-interacting serine/threonine-protein kinase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Receptor-interacting serine/threonine-protein kinase 1